SE9801705D0 - Biologically active composition - Google Patents

Biologically active composition

Info

Publication number
SE9801705D0
SE9801705D0 SE9801705A SE9801705A SE9801705D0 SE 9801705 D0 SE9801705 D0 SE 9801705D0 SE 9801705 A SE9801705 A SE 9801705A SE 9801705 A SE9801705 A SE 9801705A SE 9801705 D0 SE9801705 D0 SE 9801705D0
Authority
SE
Sweden
Prior art keywords
biologically active
active agent
carrier
chemical operation
active composition
Prior art date
Application number
SE9801705A
Other languages
English (en)
Inventor
Aake Lindahl
Haakan Hagslaett
Catharina Heiman
Rikard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Priority to SE9801705A priority Critical patent/SE9801705D0/sv
Publication of SE9801705D0 publication Critical patent/SE9801705D0/sv
Priority to DE69912271T priority patent/DE69912271T2/de
Priority to DK99927062T priority patent/DK1077677T3/da
Priority to NZ508074A priority patent/NZ508074A/xx
Priority to IL13957799A priority patent/IL139577A0/xx
Priority to DE1077677T priority patent/DE1077677T1/de
Priority to CN99808549A priority patent/CN1309554A/zh
Priority to AU44051/99A priority patent/AU742921B2/en
Priority to TR2000/03588T priority patent/TR200003588T2/xx
Priority to PL99344221A priority patent/PL344221A1/xx
Priority to EP99927062A priority patent/EP1077677B1/en
Priority to KR1020007012709A priority patent/KR100766998B1/ko
Priority to PCT/SE1999/000824 priority patent/WO1999058109A1/en
Priority to HU0102002A priority patent/HUP0102002A3/hu
Priority to AT99927062T priority patent/ATE252371T1/de
Priority to JP2000547961A priority patent/JP2002514588A/ja
Priority to CA002332110A priority patent/CA2332110A1/en
Priority to ES99927062T priority patent/ES2155049T3/es
Priority to ZA200006476A priority patent/ZA200006476B/xx
Priority to IL139577A priority patent/IL139577A/en
Priority to NO20005725A priority patent/NO20005725L/no
Priority to GR20010300014T priority patent/GR20010300014T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
SE9801705A 1998-05-14 1998-05-14 Biologically active composition SE9801705D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
ES99927062T ES2155049T3 (es) 1998-05-14 1999-05-12 Procedimiento para la fabricacion de un composicion biologicamente activa.
EP99927062A EP1077677B1 (en) 1998-05-14 1999-05-12 Process for the manufacture of a biologically active composition
PCT/SE1999/000824 WO1999058109A1 (en) 1998-05-14 1999-05-12 Biologically active composition
NZ508074A NZ508074A (en) 1998-05-14 1999-05-12 Biologically active compositions, and methods for their preparation, comprising a carrier matrix supersaturated with active agent
IL13957799A IL139577A0 (en) 1998-05-14 1999-05-12 Biologically active composition
DE1077677T DE1077677T1 (de) 1998-05-14 1999-05-12 Biologisch aktive zusammensetzung
CN99808549A CN1309554A (zh) 1998-05-14 1999-05-12 生物活性组合物
AU44051/99A AU742921B2 (en) 1998-05-14 1999-05-12 Biologically active composition
TR2000/03588T TR200003588T2 (tr) 1998-05-14 1999-05-12 Biyolojik olarak aktif bileşim
PL99344221A PL344221A1 (en) 1998-05-14 1999-05-12 Biologically active composition
DE69912271T DE69912271T2 (de) 1998-05-14 1999-05-12 Verfahren zur Herstellung einer biologisch wirksamen Zusammensetzung
KR1020007012709A KR100766998B1 (ko) 1998-05-14 1999-05-12 생물학적 활성 조성물
DK99927062T DK1077677T3 (da) 1998-05-14 1999-05-12 Fremgangsmåde til fremstilling af en biologisk aktiv sammensætning
HU0102002A HUP0102002A3 (en) 1998-05-14 1999-05-12 Biologically active composition and process for its preparation
AT99927062T ATE252371T1 (de) 1998-05-14 1999-05-12 Verfahren für die herstellung einer biologisch aktiven zusammensetzung
JP2000547961A JP2002514588A (ja) 1998-05-14 1999-05-12 生物活性組成物
CA002332110A CA2332110A1 (en) 1998-05-14 1999-05-12 Biologically active composition
IL139577A IL139577A (en) 1998-05-14 2000-11-09 A biologically active preparation and a process for its production
ZA200006476A ZA200006476B (en) 1998-05-14 2000-11-09 Biologically active composition.
NO20005725A NO20005725L (no) 1998-05-14 2000-11-13 Biologisk aktiv sammensetning
GR20010300014T GR20010300014T1 (en) 1998-05-14 2001-04-30 Biologically active composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition

Publications (1)

Publication Number Publication Date
SE9801705D0 true SE9801705D0 (sv) 1998-05-14

Family

ID=20411319

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801705A SE9801705D0 (sv) 1998-05-14 1998-05-14 Biologically active composition

Country Status (20)

Country Link
EP (1) EP1077677B1 (sv)
JP (1) JP2002514588A (sv)
KR (1) KR100766998B1 (sv)
CN (1) CN1309554A (sv)
AT (1) ATE252371T1 (sv)
AU (1) AU742921B2 (sv)
CA (1) CA2332110A1 (sv)
DE (2) DE1077677T1 (sv)
DK (1) DK1077677T3 (sv)
ES (1) ES2155049T3 (sv)
GR (1) GR20010300014T1 (sv)
HU (1) HUP0102002A3 (sv)
IL (2) IL139577A0 (sv)
NO (1) NO20005725L (sv)
NZ (1) NZ508074A (sv)
PL (1) PL344221A1 (sv)
SE (1) SE9801705D0 (sv)
TR (1) TR200003588T2 (sv)
WO (1) WO1999058109A1 (sv)
ZA (1) ZA200006476B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280485A4 (en) * 2000-02-29 2006-11-29 Zars Inc TRANSDERMAL STAMP FOR IMPROVED MEDICINE
CN1845725A (zh) * 2003-08-06 2006-10-11 尼马尔·穆利耶 包含水溶性药物的药物组合物
AU2007260739A1 (en) 2006-06-14 2007-12-21 Dr. Reddy's Laboratories Limited Topical compositions
WO2012028496A1 (de) * 2010-08-31 2012-03-08 Basf Se Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung
WO2012097264A2 (en) * 2011-01-13 2012-07-19 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940701A (en) * 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) * 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
AU742921B2 (en) 2002-01-17
EP1077677B1 (en) 2003-10-22
TR200003588T2 (tr) 2001-06-21
ZA200006476B (en) 2001-06-11
NZ508074A (en) 2003-01-31
DK1077677T3 (da) 2004-02-16
DE1077677T1 (de) 2001-09-20
NO20005725L (no) 2001-01-11
JP2002514588A (ja) 2002-05-21
KR100766998B1 (ko) 2007-10-15
HUP0102002A3 (en) 2002-12-28
PL344221A1 (en) 2001-10-08
IL139577A (en) 2007-07-04
IL139577A0 (en) 2002-02-10
HUP0102002A2 (hu) 2002-03-28
EP1077677A1 (en) 2001-02-28
WO1999058109A1 (en) 1999-11-18
ATE252371T1 (de) 2003-11-15
ES2155049T3 (es) 2004-05-16
GR20010300014T1 (en) 2001-04-30
CA2332110A1 (en) 1999-11-18
KR20010052349A (ko) 2001-06-25
NO20005725D0 (no) 2000-11-13
DE69912271T2 (de) 2004-08-26
DE69912271D1 (de) 2003-11-27
CN1309554A (zh) 2001-08-22
AU4405199A (en) 1999-11-29
ES2155049T1 (es) 2001-05-01

Similar Documents

Publication Publication Date Title
ES2118677T3 (es) Una composicion que comprende un agente activo disuelto en un vehiculo formador de vidrio y un procedimiento para su preparacion.
DE59607548D1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln
TR199900353T2 (xx) Kontroll� salma sa�layan cihazlar�n yap�m� i�in y�ntem.
NO954957L (no) Synergistisk stabiliserte flytende enzymatiske blandinger
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
DE1077677T1 (de) Biologisch aktive zusammensetzung
ATE310500T1 (de) Biologisch aktive zusammensetzung
MD1360C2 (ro) Compoziţie fungicidă, procedeu de combatere şi prevenire a infectării cu Oomicete a plantelor
ATE290387T1 (de) Ribavirin-granulat zur herstellung von filmtabletten
KR900001830A (ko) 트리폴리포스페이트를 함유하는 액상 세제의 제조방법
SU1820809A1 (ru) Лазерное вещество
JPS57136503A (en) Expellent for noxious mollusk
KR910002493A (ko) 다공질화산암(多孔質火山岩)을 활용한 공해방지제 (公害防止劑)의 제조방법
KR830007470A (ko) 활성무기 식물영양제(活性無機植物營養劑)
TH48057A3 (th) สารผสมที่จะเพิ่มการยอมให้ผ่านของตัวกระทำเฉพาะที่ผิวหนัง
TH1086A (th) ส่วนประกอบสารทำให้ผ้านุ่ม